1. Home
  2. JHX vs AXSM Comparison

JHX vs AXSM Comparison

Compare JHX & AXSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo James Hardie Industries plc (Ireland)

JHX

James Hardie Industries plc (Ireland)

HOLD

Current Price

$25.70

Market Cap

14.0B

Sector

Industrials

ML Signal

HOLD

Logo Axsome Therapeutics Inc.

AXSM

Axsome Therapeutics Inc.

HOLD

Current Price

$240.26

Market Cap

12.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
JHX
AXSM
Founded
1888
2012
Country
Ireland
United States
Employees
7500
N/A
Industry
Building Materials
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
14.0B
12.0B
IPO Year
N/A
2015

Fundamental Metrics

Financial Performance
Metric
JHX
AXSM
Price
$25.70
$240.26
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
9
17
Target Price
$27.83
$211.12
AVG Volume (30 Days)
7.8M
867.2K
Earning Date
05-19-2026
05-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
38.56
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$26.06
$57.24
Revenue Next Year
$14.50
$55.88
P/E Ratio
$122.05
N/A
Revenue Growth
N/A
N/A
52 Week Low
$16.46
$96.09
52 Week High
$29.83
$260.19

Technical Indicators

Market Signals
Indicator
JHX
AXSM
Relative Strength Index (RSI) 60.28 51.70
Support Level $19.15 $236.44
Resistance Level $27.06 $260.19
Average True Range (ATR) 0.86 8.87
MACD -0.03 -1.82
Stochastic Oscillator 62.59 16.25

Price Performance

Historical Comparison
JHX
AXSM

About JHX James Hardie Industries plc (Ireland)

James Hardie is a manufacturer of fiber cement-based building products, selling primarily to the residential construction industry. North America is the primary geography, generating about 80% of group earnings. Here, it is the largest manufacturer of fiber cement, which is mainly used for exterior siding on houses. Following the Azek acquisition in 2025, it also produces wooden composite decking materials, siding trims, and accessories for outdoor areas including stair and deck railing. Businesses in Australia, New Zealand, and Europe, make up the rest of earnings.

About AXSM Axsome Therapeutics Inc.

Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products include AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.

Share on Social Networks: